Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management

Mario Sznol1, Michael A Postow2, Marianne J Davies3

  • 1Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.

Insights

Immune checkpoint inhibitors for cancer can cause endocrine-related side effects affecting glands like the pituitary and thyroid. Early recognition and management are key for safe treatment.

Area of Science:

  • Oncology
  • Immunology
  • Endocrinology

Background:

  • Immune checkpoint inhibitors targeting CTLA-4 and PD-1 are crucial cancer therapies.
  • These therapies can lead to immune-related adverse events (irAEs) affecting various organs.
  • Endocrine irAEs impact the pituitary, thyroid, and adrenal glands, often irreversibly.

Purpose of the Study:

  • To review the characteristics of immune-related endocrine events associated with immune checkpoint inhibitors.
  • To highlight the diagnostic challenges and management strategies for these events.
  • To emphasize the importance of awareness for safe clinical practice.

Main Methods:

  • Literature review of immune checkpoint inhibitors and their associated endocrine adverse events.
  • Analysis of the presentation, diagnosis, and management of immune-related endocrine events.
  • Synthesis of current understanding regarding mechanisms and clinical implications.

Main Results:

  • Immune-related endocrine events are common, often irreversible, and present with non-specific symptoms.
  • Diagnosis can be challenging due to mild severity (Grade 1/2) and subtle manifestations.
  • Management involves monitoring, hormone replacement, and specialist consultation.

Conclusions:

  • Immune-related endocrine events require vigilant monitoring and prompt management.
  • Understanding these events is crucial for the safe and effective use of immune checkpoint inhibitors.
  • Further research into underlying mechanisms may improve patient outcomes.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
957
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
941
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
547
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
266